TABLE 2.
Multivariate analysis of risk factors for acquisition of P. aeruginosa with the Fepns Cazs phenotype in 23 infected patients
| Risk factor | Control group 1
|
Control group 2
|
||
|---|---|---|---|---|
| OR (95% CI)a | P | OR (95% CI) | P | |
| Underlying disease (Charlson index > 2) | 0.2 (0.03-1.2) | 0.08 | 0.4 (0.07-2.2) | 0.2 |
| Receipt of piperacillin-tazobactam | 22.4 (3.5-141.1) | <0.01 | 7.3 (1.5-34.0) | 0.01 |
| Receipt of fluoroquinolones | 12.3 (1.3-113.4) | 0.02 | ||
| Receipt of aminoglycosides | 1.5 (0.1-12.4) | 0.6 | 6.8 (0.6-70.1) | 0.1 |
a
OR, odds ratio; CI, confidence interval.